BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11257394)

  • 1. Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to Humans.
    Fritsch EF; Ott PA
    Cancer Res; 2024 Apr; 84(7):953-955. PubMed ID: 38558128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new vaccines: building viruses that elicit antitumor immunity.
    Restifo NP
    Curr Opin Immunol; 1996 Oct; 8(5):658-63. PubMed ID: 8902391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized DNA Vaccine Immunogenic Against Melanoma.
    Cancer Discov; 2024 Jan; 14(1):8-9. PubMed ID: 37937932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a plant-produced colorectal cancer antigen.
    Verch T; Hooper DC; Kiyatkin A; Steplewski Z; Koprowski H
    Cancer Immunol Immunother; 2004 Feb; 53(2):92-9. PubMed ID: 14566428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene profiling analysis of ALVAC infected human monocyte derived dendritic cells.
    Harenberg A; Guillaume F; Ryan EJ; Burdin N; Spada F
    Vaccine; 2008 Sep; 26(39):5004-13. PubMed ID: 18691624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination.
    Vijaysri S; Jentarra G; Heck MC; Mercer AA; McInnes CJ; Jacobs BL
    Vaccine; 2008 Jan; 26(5):664-76. PubMed ID: 18096276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genome of canarypox virus.
    Tulman ER; Afonso CL; Lu Z; Zsak L; Kutish GF; Rock DL
    J Virol; 2004 Jan; 78(1):353-66. PubMed ID: 14671117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract.
    Liang W; Wang H; Sun TM; Yao WQ; Chen LL; Jin Y; Li CL; Meng FJ
    World J Gastroenterol; 2003 Mar; 9(3):495-8. PubMed ID: 12632504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunization: leaps into the future. The vaccinology at the beginning of the 21th century (II)].
    Navarro Alonso JA
    Aten Primaria; 2002 Jun; 30(2):130-3. PubMed ID: 12106566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New vaccine development.
    Poland GA; Murray D; Bonilla-Guerrero R
    BMJ; 2002 Jun; 324(7349):1315-9. PubMed ID: 12039828
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel design architecture for genetic stability of recombinant poliovirus: the manipulation of G/C contents and their distribution patterns increases the genetic stability of inserts in a poliovirus-based RPS-Vax vector system.
    Lee SG; Kim DY; Hyun BH; Bae YS
    J Virol; 2002 Feb; 76(4):1649-62. PubMed ID: 11799160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor vaccines: conception, development and evaluation in humans].
    Moingeon P
    Ann Pharm Fr; 2002 Jul; 60(4):253-9. PubMed ID: 12378152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses.
    Hodge JW; McLaughlin JP; Kantor JA; Schlom J
    Vaccine; 1997; 15(6-7):759-68. PubMed ID: 9178479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells.
    Motta I; André F; Lim A; Tartaglia J; Cox WI; Zitvogel L; Angevin E; Kourilsky P
    J Immunol; 2001 Aug; 167(3):1795-802. PubMed ID: 11466405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant viruses as a tool for therapeutic vaccination against human cancers.
    Bonnet MC; Tartaglia J; Verdier F; Kourilsky P; Lindberg A; Klein M; Moingeon P
    Immunol Lett; 2000 Sep; 74(1):11-25. PubMed ID: 10996623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic vaccines against melanoma and colorectal cancer.
    Tartaglia J; Bonnet MC; Berinstein N; Barber B; Klein M; Moingeon P
    Vaccine; 2001 Mar; 19(17-19):2571-5. PubMed ID: 11257394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant cancer vaccines based on viral vectors.
    Moingeon P
    Dev Biol (Basel); 2004; 116():117-22; discussion 133-43. PubMed ID: 15603188
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.